G Medical Innovations Holdings Ltd (GMVDF)

GMVDF Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	4.42	4.96	4.9	5.53	3.06
Revenue Growth (YoY)	-10.90%	1.24%	-11.33%	80.47%	2709.17%
Cost of Revenue	3.64	3.45	4.23	5.75	2.99
Gross Profit	0.78	1.51	0.67	-0.22	0.07
Selling, General & Admin	20.61	10.8	11.65	10	12.82
Research & Development	2.29	1.68	1.32	2.55	4.14
Operating Expenses	28.19	12.48	12.97	12.56	17.25
Operating Income	-27.41	-10.97	-12.3	-12.78	-17.18
Interest Expense	-4.08	-0.82	-0.46	-1.4	-0.99
Interest & Investment Income	-	-	-	-	0.16
Other Non Operating Income (Expenses)	17.55	-2.81	0.06	-2.19	0.7
Pretax Income	-13.94	-14.59	-12.71	-16.37	-17.32
Income Tax Expense	0.02	-0	-0.02	-0.86	-0.35
Earnings From Continuing Operations	-13.96	-14.59	-12.69	-15.51	-16.98
Minority Interest in Earnings	0.44	0.13	0.15	0.5	0.71
Net Income	-13.52	-14.46	-12.54	-15.01	-16.26
Net Income to Common	-13.52	-14.46	-12.54	-15.01	-16.26
Shares Outstanding (Basic)	1	0	0	0	0
Shares Outstanding (Diluted)	1	0	0	0	0
Shares Change (YoY)	122.18%	54.45%	70.77%	12.15%	47.52%
EPS (Basic)	-18.76	-44.56	-59.68	-122.04	-148.26
EPS (Diluted)	-18.76	-44.56	-59.68	-122.04	-148.26
Free Cash Flow	-20.6	-12.04	-5.15	-6.73	-17.82
Free Cash Flow Per Share	-28.58	-37.12	-24.54	-54.68	-162.47
Gross Margin	17.74%	30.42%	13.61%	-4.04%	2.22%
Operating Margin	-620.14%	-221.08%	-251.02%	-231.25%	-561.20%
Profit Margin	-305.91%	-291.41%	-255.84%	-271.68%	-531.09%
Free Cash Flow Margin	-466.06%	-242.77%	-105.18%	-121.72%	-582.00%
EBITDA	-26.65	-9.93	-10.88	-9.91	-14.51
EBITDA Margin	-	-200.16%	-222.08%	-179.32%	-
D&A For EBITDA	0.76	1.04	1.42	2.87	2.68
EBIT	-27.41	-10.97	-12.3	-12.78	-17.18
EBIT Margin	-	-221.08%	-251.02%	-231.25%	-
Revenue as Reported	4.42	4.96	4.9	5.53	3.06

Updated May 16, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.